A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long-term risk profile of abatacept.
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
Pisanu C.;
2014-01-01
Abstract
A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to establish the long-term risk profile of abatacept.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Deidda et al., 2014.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
versione editoriale
Dimensione
435.53 kB
Formato
Adobe PDF
|
435.53 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
